lupus patients put on a new IV monoclonal antibody, Benlysta (ben-LIST-a, belimumab)

May 2011

You might see some of your lupus patients put on a new IV monoclonal antibody, Benlysta (ben-LIST-a, belimumab).

This IV drug is only for severe systemic lupus erythematosus.

It's the first new lupus drug in 50 years...and the first biologic.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote